That’s a tall order, because batteries make up about 40 percent of an EV’s cost, and the cells themselves dominate that ...

AN inmate has been charged with escaping from prison on New Year’s Day, while two others remain at large – including a convicted ...

Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...

Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...